The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland

BACKGROUND: Mandatory generic substitution (GS) was introduced in Finland on 1 April 2003. The aim of this study was to explore and compare the impacts of GS on the activities of pharmaceutical companies representing mainly original or generic pharmaceutical products in Finland. The self-reported im...

Descripción completa

Detalles Bibliográficos
Autores principales: Timonen, Johanna, Bengtström, Marina, Karttunen, Pekka, Ahonen, Riitta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974660/
https://www.ncbi.nlm.nih.gov/pubmed/20964869
http://dx.doi.org/10.1186/1472-6904-10-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974660/
https://www.ncbi.nlm.nih.gov/pubmed/20964869
http://dx.doi.org/10.1186/1472-6904-10-15

Ejemplares similares